Pestivirus marker vaccine
AssigneeIntervet Inc.
InventorsIlona REIMANN, Patricia KONIG, Martin BEER
Life of this patent
Estimating the term…
Abstract
The present invention provides a mutant Pestivirus comprising a chimeric Erns gene, which provides the mutant Pestivirus with the capacity to evade serologic detection, but maintains good vaccine properties, and viral replication.
Claims46
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A mutant Pestivirus comprising a genome wherein an Erns gene is mutated, wherein said mutated Erns gene is a chimeric Erns gene, wherein said chimeric Erns gene comprises a 5′ part and a 3′ part, wherein said 5′ part comprises 60-95% of the chimeric Erns gene, wherein said 3′ part comprises the remainder of the chimeric Erns gene, wherein said 5′ part comprises the corresponding part of an Erns gene from a Pestivirus that is genetically distant from the mutant Pestivirus, and wherein said 3′ part comprises the corresponding part of an Erns gene from a Pestivirus that is genetically close to the mutant Pestivirus.
Dependencies are inferred from the claim text.